The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has provided a positive opinion recommending the conditional marketing authorization (CMA) of Pfizer’s oral therapy for Covid-19, Paxlovid. Paxlovid is intended to […]
Cocrystal Pharma has announced the selection of two investigational antiviral drug candidates, CDI-988 and CDI-873, to further develop them as oral therapies to treat Covid-19. The new broad-spectrum oral candidates act on a conserved area […]
Screening for premalignant precursor conditions could serve as an important step in the early detection and treatment of multiple myeloma. However, more insights are needed to determine the optimal criteria for screening programs, experts say, […]
Zydus has commenced the delivery of the first consignment of its Covid-19 deoxyribonucleic acid (DNA) Plasmid vaccine, ZyCoV-D, to the Government of India. On administration, the vaccine generates the SARS-CoV-2 viral spike protein and induces […]
Delivery Innovations in Formulation and Device Design for Enhanced Subcutaneous As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use of […]